National Guideline Clearinghouse | Zoledronic acid for the treatment of bone metastases secondary to renal cell carcinoma.

Guideline Title
Zoledronic acid for the treatment of bone metastases secondary to renal cell carcinoma.

Bibliographic Source(s)
MacKenzie M, Quinton-Gladstone C, Haynes AE, Hotte S. Zoledronic acid for the treatment of bone metastases secondary to renal cell carcinoma. Toronto (ON): Cancer Care Ontario (CCO); 2010 Jun 16. 14 p. (Special advice report; no. 18). [18 references]

Guideline Status
This is the current release of the guideline.

The SPECIAL ADVICE REPORT over time will expand to contain new information emerging from their reviewing and updating activities.

Please visit the Cancer Care Ontario Web site [http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=75968] for details on any new evidence that has emerged and implications to the guidelines.

full-text:
National Guideline Clearinghouse | Zoledronic acid for the treatment of bone metastases secondary to renal cell carcinoma.